Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

exchanges : Amex    crawled time : 13:00    save search

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
Published: 2024-04-19 (Crawled : 13:00) - globenewswire.com
CRMD | $5.33 -2.2% -2.06% 420K twitter stocktwits trandingview |
Health Technology
| | O: 1.66% H: 13.09% C: -4.0%

defencath grants
AgEagle Aerial Systems eBee VISION Drones Impress at Global Government and Military Events
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
UAVS | $0.76 2.77% -0.13% 190K twitter stocktwits trandingview |
Electronic Technology
| | O: 2.34% H: 0.0% C: 0.0%

drones global vision military
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
CRMD | $5.33 -2.2% -2.06% 420K twitter stocktwits trandingview |
Health Technology
| | O: 2.4% H: 3.18% C: -10.03%

defencath commercial
Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
CANF | $1.94 -1.52% 0.0% 5.7K twitter stocktwits trandingview |
Health Technology
| | O: 4.76% H: 0.45% C: -5.91%

drug candidate liver cancer treat namodenoson advanced
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
Published: 2024-04-11 (Crawled : 13:00) - globenewswire.com
CRMD | $5.33 -2.2% -2.06% 420K twitter stocktwits trandingview |
Health Technology
| | O: 2.46% H: 18.3% C: 18.11%

america conference for
Regional Health Properties Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-08 (Crawled : 13:00) - globenewswire.com
RHE | $2.94 2.8% 0.0% 5.9K twitter stocktwits trandingview |
Finance
| | O: 1.84% H: 3.03% C: 3.03%

health year financial results
CTO Realty Growth Announces Pricing of Public Offering of 6.375% Series A Cumulative Redeemable Preferred Stock
Published: 2024-04-04 (Crawled : 13:00) - globenewswire.com
PINE | $15.07 -2.59% 1.79% 33K twitter stocktwits trandingview |
Finance
| | O: -0.68% H: 0.98% C: -1.77%
CTO | $17.16 -0.23% 0.0% 150K twitter stocktwits trandingview |
Finance
| | O: 1.2% H: 0.71% C: -0.59%

series offering realty growth
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
Published: 2024-04-03 (Crawled : 13:00) - globenewswire.com
MLSS A | $0.559 0.34% 0.0% 38K twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 6.95% C: -1.53%

compuflo sales milestone
Kelso Technologies Inc. Financial Results for the Year Ended December 31, 2023
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
KIQ | $0.1349 0.0% 12K twitter stocktwits trandingview |
Producer Manufacturing
| Email alert Add to watchlist

year financial results
American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
AMS | $3.02 0.84% 0.0% 15K twitter stocktwits trandingview |
Health Services
| | O: 0.03% H: 2.1% C: 0.17%

ceo services hospital
Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response
Published: 2024-03-22 (Crawled : 13:00) - globenewswire.com
MTNB | $0.1818 0.17% 2.04% 520K twitter stocktwits trandingview |
Health Technology
| | O: 8.94% H: 48.28% C: -4.14%

mat2203 infection program response
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
Published: 2024-03-14 (Crawled : 13:00) - globenewswire.com
MLSS A | $0.559 0.34% 0.0% 38K twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.0% C: -4.0%

compuflo sales milestone
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - globenewswire.com
APT | $5.98 -0.66% 0.0% 25K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -0.97%

pro year financial results
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
ERNA | $1.74 -11.22% -8.89% 13K twitter stocktwits trandingview |
Information
| | O: 4.1% H: 0.0% C: -11.81%
LCTX | $1.1 -3.51% 0.0% 750K twitter stocktwits trandingview |
Health Technology
| | O: 1.61% H: 2.38% C: -3.97%

rg6501 opregen innovation cell therapy results study
Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients
Published: 2024-03-08 (Crawled : 13:00) - globenewswire.com
DXR | $9.9399 1.43% 0.73% 1K twitter stocktwits trandingview |
Health Technology
| | O: 2.71% H: 0.25% C: -0.88%

conference unique heart therapeutics study
A Natural Gas Boom Is Looming For Europe
Published: 2024-03-07 (Crawled : 13:00) - prnewswire.com
TALO | $13.53 -1.6% 0.0% 1.4M twitter stocktwits trandingview |
Energy Minerals
| | O: 0.31% H: 0.39% C: -2.72%
XOM | $121.05 0.02% -0.12% 10M twitter stocktwits trandingview |
Energy Minerals
| | O: -0.16% H: 1.29% C: 0.72%
COP 4 | $129.28 -0.43% 0.01% 3M twitter stocktwits trandingview |
Energy Minerals
| | O: -0.23% H: 1.52% C: 0.9%
CVX | $163.57 0.44% -0.1% 6.4M twitter stocktwits trandingview |
Energy Minerals
| | O: 0.11% H: 1.51% C: 0.59%
LNG | $157.42 -0.93% 0.0% 2.1M twitter stocktwits trandingview |
Industrial Services
| | O: 0.03% H: 0.87% C: 0.3%

europe natural gas
ASHFORD ANNOUNCES ACCEPTANCE OF COMPLIANCE PLAN BY NYSE AMERICAN
Published: 2024-03-01 (Crawled : 13:00) - prnewswire.com
AINC 4 | $4.8 0.42% 0.0% 37K twitter stocktwits trandingview |
Finance
| | O: 0.36% H: 21.43% C: 13.21%


Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
ANVS | $12.74 7.24% 0.0% 430K twitter stocktwits trandingview |
Health Technology
| | O: -0.68% H: 12.15% C: 11.12%


Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access Program, Including Multiple Patients with Complete Clinical Resolution
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
MTNB | $0.1818 0.17% 2.04% 520K twitter stocktwits trandingview |
Health Technology
| | O: 1.59% H: 15.13% C: 10.61%

mat2203 positive update biopharma
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
DXR | $9.9399 1.43% 0.73% 1K twitter stocktwits trandingview |
Health Technology
| | O: 0.13% H: 7.91% C: -3.02%

conference corporation heart technology therapeutics
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.